SS
Sunil Subhash Bhagwat
About Sunil Subhash Bhagwat
Data last updated:
Sunil Subhash Bhagwat is an Additional Director at Supriya Lifescience Limited (since 2025), Director at I-Hub Quantum Technology Foundation (since 2023) and Director at Aic Iiser Pune Seed Foundation (since 2023). The companies operate in Pharma and Research & Development. The 3 current companies with reported revenue have a combined latest revenue of ₹847 Cr; the largest is Supriya Lifescience Limited at ₹839 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 24 Jan 2025 | 2008 | ₹839 Cr (FY 2026) | Active | |
| Director | 18 Sep 2023 | 2021 | ₹6.78 Cr (FY 2024) | Active | |
| Director | 29 Sep 2023 | 2018 | ₹1.16 Cr (FY 2026) | Active |
Board colleagues of Sunil Subhash Bhagwat
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Subhash Bhagwat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Subhash Bhagwat
Sunil Subhash Bhagwat currently holds 3 directorships: Supriya Lifescience Limited (Additional Director, since 24 Jan 2025, revenue ₹839 Cr (FY 2026)); I-Hub Quantum Technology Foundation (Director, since 18 Sep 2023, revenue ₹6.78 Cr (FY 2024)); Aic Iiser Pune Seed Foundation (Director, since 29 Sep 2023, revenue ₹1.16 Cr (FY 2026)).
Sunil Subhash Bhagwat was first appointed on 18 Sep 2023 as Director at I-Hub Quantum Technology Foundation. The most recent appointment on record is 24 Jan 2025 at Supriya Lifescience Limited.
The 3 current companies of Sunil Subhash Bhagwat that report revenue have a combined latest revenue of ₹847 Cr: Supriya Lifescience Limited ₹839 Cr (FY 2026); I-Hub Quantum Technology Foundation ₹6.78 Cr (FY 2024); Aic Iiser Pune Seed Foundation ₹1.16 Cr (FY 2026).
The current boards of Sunil Subhash Bhagwat's companies include Balasaheb Gulabrao Sawant (Supriya Lifescience Limited), Ganapati Dadasaheb Yadav (Supriya Lifescience Limited), Kothandaraman Hari (Supriya Lifescience Limited), Krishna Raghunathan (Supriya Lifescience Limited), Manish Ishwarlal Panchal (Supriya Lifescience Limited), Neelam Yashpal Arora (Supriya Lifescience Limited), among others.